Biocept's Target Selector test enables physicians to identify the potential presence of NTRK fusions used to inform on treatment options.
The kit is designed for purification of circulating cfNDA and uses silica coated paramagnetic particles to purify cfDNA from less than 1 mL to greater than 10 mL of serum or plasma.
Each of the new panels comes with ERASE-Seq, Fluxion's variant caller which uses statistical analysis to compare sequencing results across several molecular amplification pools.
Liquid biopsy test provider Biocept has announced Target Selector NGS Breast Panel, a multi-gene liquid biopsy panel specifically developed for breast cancer. The Target...
PerkinElmer has introduced the PG-Seq Rapid Non-Invasive Preimplantation Genetic Testing for Aneuploidy (PGT-A) kit, that tests spent embryo culture media for chromosomal abnormalities during in vitro fertilization (IVF) treatment.
ChIP-Seq Spike-in corrects for technical variation that occurs as a result of the multistep ChIP/ChIP-Seq protocols.
NanoString Technologies has announced the launch of nCounter Human Organ Transplant, a gene expression panel for researchers to evaluate the human immune response following organ transplantation.
The ZymoPURE™ Plasmid Miniprep Kit yields up to 80 µg of ultra-pure and highly concentrated plasmid DNA.
This new system features automation from the primary sample tube, greater traceability, and higher throughput.
The ampDRY hotstart master mix was developed to enable complete end-stage or real-time PCR assay stabilization in a dry format.